| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CLCD | CoLucid Pharmaceuticals, Inc. | Dallas Matthew D | Chief Financial Officer | Mar 01, 2017 | Option Exercise | $46.50 | 40,208 | 1,869,672 | 0 | Mar 01, 2017, 12:12 PM | |
| CLCD | CoLucid Pharmaceuticals, Inc. | Dallas Matthew D | Chief Financial Officer | Jan 03, 2017 | Sale | $36.25 | 1,473 | 53,396 | 40,128 | Jan 04, 2017, 04:24 PM | |
| CLCD | CoLucid Pharmaceuticals, Inc. | Dallas Matthew D | Chief Financial Officer | Dec 01, 2016 | Sale | $35.17 | 1,473 | 51,801 | 41,601 | Dec 01, 2016, 04:43 PM | |
| AVEO | AVEO PHARMACEUTICALS INC | Dallas Matthew D | VP, Finance | Jan 16, 2015 | Sale | $0.82 | 3,075 | 2,512 | 14,506 | Jan 20, 2015, 04:32 PM | |
| AVEO | AVEO PHARMACEUTICALS INC | Dallas Matthew D | VP, Finance | Jan 07, 2015 | Sale | $0.80 | 519 | 415 | 17,581 | Jan 08, 2015, 04:30 PM |
Menu